Probiotics help maintain a healthy lifestyle that has increased their consumption among numerous end-users worldwide. They have shown excellent results in maternal & geriatric health, which are some other crucial segments across which their demand has notably upsurged. The probiotic ingredients in the human nutrition industry witnessed a steady growth during 2017-20 due to the mounting inclination of consumers toward immunity booster products, surging consumption of functional foods, growing awareness regarding probiotic-based products, and rising health concerns over gastrointestinal issues. This burgeoning adoption of probiotic ingredients in dairy & non-dairy-based products has made them immensely popular among a wider audience globally.
The Global Probiotic Ingredients in Human Nutrition Market is anticipated to grow at a CAGR of around 8.4 % during the forecast period, i.e., 2022-27. The mounting trend of probiotic ingredients in dietary supplements to prevent gastrointestinal issues & cardiovascular diseases drives the market.
Moreover, health awareness among consumers worldwide is on the rise, wherein most consumers are constantly looking for healthy food products for daily consumption. Probiotics promote incredible health benefits, more specifically to the human digestive system. They are found either in the supplement form or as components of foods & beverages. Their integration into inexpensive health foods like yogurt, fruit juices, and cultured dairy drinks has significantly contributed to the overall market expansion.
|Study Period||Historical Data: 2017-20|
|Base Year: 2021|
|Forecast Period: 2022-27|
|Regions Covered||North America: USA, Canada, Mexico|
|Europe: Germany, The UK, France, Spain, Italy and Others|
|Asia-Pacific: China, India, Japan, South Korea, Australia and Others|
|South America: Brazil, and Argentina|
|Middle East & Africa: Saudi Arabia, UAE, Israel, Egypt, Turkey, South Africa|
|Key Companies Profiled||Kerry Group, DuPont de Nemours, Inc. Chr. Hansen, BioGaia, Probi AB, GLAC Biotech Group, Deerland Probiotics & Enzymes, Lallemand Inc., United Agricultural Services Laboratories, Biena, LESAFFRE Morrinaga, Yakult Honsha, Archer Daniel Midland Company, Danone, Nestle S.A|
|Unit Denominations||USD Million/Billion|
Probiotics aid in the prevention & cure of various diseases, such as gastrointestinal, cardiovascular, etc., which is why their demand is likely to increase significantly as Over-The-Counter (OTC) drugs. Moreover, increasing health benefits associated with probiotics would enhance the trend of cost-effective, safe, & natural alternatives to drugs globally. The majority of the population worldwide suffers from gastrointestinal diseases, such as Irritable Bowel Syndrome, which can be prevented by using probiotic food products. Various research activities across the globe have been conducted to illustrate the prevalence of gastrointestinal diseases. For instance:
Intake of probiotic medical supplement powders, tablets, & capsules helps reduce symptoms of various medical conditions and promote immunity. The continuous mutation in the variants of Covid-19 (Delta, Omicron, etc.) is another crucial aspect likely to infuse their demand as immunity boosters in the coming years. Moreover, probiotic drinks prevent the growth of harmful bacteria inside the digestive tract, which is why the demand for probiotic ingredients has increased significantly in the healthcare sector, and several pharmaceutical companies have introduced various products based on probiotic ingredients. For instance:
However, since most probiotics fall under the food or dietary supplement categories, they must be proven safe & effective for their intended use through clinical trials and approved by the FDA before they get sold. This fact, in turn, is a significant challenge for pharmaceutical companies to launch new products in the market and build consumer trust toward them.